Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts. [electronic resource]
Producer: 20170615Description: 2653-2664 p. digitalISSN:- 1538-8514
- Animals
- Antineoplastic Agents -- pharmacology
- Antioxidants -- pharmacology
- Apoptosis -- drug effects
- Caspases -- metabolism
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cytochromes c -- metabolism
- Disease Models, Animal
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Fenretinide -- pharmacology
- Humans
- Membrane Potential, Mitochondrial -- drug effects
- Mice
- Neoplasm Recurrence, Local
- Neuroblastoma -- drug therapy
- Reactive Oxygen Species -- metabolism
- Sulfonamides -- pharmacology
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.